Record Ratings Earnings Still Depend on an Issuance Recovery

Results vs. Consensus

For the quarter ended March 31, 2026, Moody’s revenue of $2.079 billion landed around expectations and adjusted EPS modestly exceeded them. Profit growth was driven by the combination of a larger revenue base and better cost absorption, rather than a major demand surprise. The investment question is whether that operating discipline can sustain earnings while issuance windows remain uneven.

Year-over-year financial comparison

Sequential financial comparison

Revenue assessment: The stronger mix of renewable analytics contracts and ratings monitoring fees supports a more durable base: recurring revenue across the group reached $1.272 billion, or 61% of sales. But MIS still supplied 55% of external revenue and most adjusted profit. Subscription growth moderates the issuance cycle; it does not remove it.

Margin assessment: The $111 million increase in adjusted operating income on $155 million more revenue implies approximately 72% incremental conversion. MA contributed $43 million and MIS $68 million. This is strong execution, but Q1’s favorable ratings seasonality makes 53.2% an unsuitable flat quarterly run rate; the full-year margin outlook remains 52–53%.

EPS assessment: Diluted shares fell to 177.3 million from 180.7 million, while adjusted net income grew 10.8% to $767 million. GAAP earnings faced a higher 24.0% tax rate versus 22.3% and the new tax-related charge. Buybacks improved per-share growth, but the operating contribution remains substantial. Sequential EPS growth also reflects the return to stronger ratings issuance after Q4, rather than a comparable acceleration in analytics.

Segment Performance

Segment adjusted margins use revenue including intersegment activity: $929 million for MA and $1,204 million for MIS. Consolidated revenue eliminates $54 million of intersegment sales. Adjusted operating income excludes depreciation and amortization, restructuring and the specified tax reserve.

Moody’s Investors Service: investment grade outweighs softer loans

Corporate Finance supplied $69 million of MIS’s $88 million revenue increase. Investment-grade revenue rose 33% against 32% issuance growth; high-yield revenue rose 31% against 21% issuance growth. Leveraged-loan revenue and issuance both fell 13%. Infrastructure supported growth, while structured finance and financial institutions provided less momentum. The strength was meaningful, but concentrated in the funding channels that remained most accessible.

“First-time mandates increased 20% year-over-year, an important leading indicator of future recurring revenue.”

— Noémie Heuland, CFO

Assessment: The 9% growth in recurring MIS revenue to $363 million and new mandates support future monitoring fees, making the quarter more than a set of jumbo deals. Even so, the $790 million transactional stream remains 69% of MIS revenue. We expect attractive incremental profitability when deferred issuance returns, with an equally direct earnings cost if those windows stay closed.

Moody’s Analytics: better contract quality, uneven growth

Banking and lending

Lending-suite ARR grew 18%, lifting banking ARR growth to 10%. Customers are adopting integrated origination, decisioning and monitoring workflows, which gives Moody’s more scope per relationship. The banking revenue decline reflects portfolio changes and lower transaction revenue; it does not describe the direction of its recurring contracts.

Assessment: Lending is a credible growth engine, but its high-teens pace should not be applied to all banking revenue. Mature products and the regulatory-solutions exit keep the segment’s reported trajectory below that of its leading suite.

Insurance and KYC

Insurance ARR grew 7%, with cloud-platform cross-selling and upselling contributing almost half of insurance net growth. Trailing retention of 97% supports the installed base. KYC ARR grew 13%, versus 15% reported at year-end, while management expects a return to mid-teens growth as the new corporate compliance offering builds.

Assessment: Insurance shows how embedded models can preserve customer relationships and support incremental sales. KYC offers more growth upside, but its rebound is a future contribution, not evidence that the entire analytics portfolio has already accelerated.

Research & Insights and Data & Information

ARR grew 7% and 6%, respectively, with customer wins spanning credit portfolios, tax enforcement and underwriting. These are useful distribution channels for proprietary data, although the growth rates remain below Decision Solutions’ 10%.

Assessment: These franchises make the analytics base more stable and provide content for enterprise AI contracts. Our near-term estimate assumes continued mid-to-high-single-digit growth, rather than treating every new distribution agreement as incremental revenue immediately.

Key KPIs

Prior retention is recast on the current methodology. ARR is measured using a constant-currency, organic contract base. Q1 excludes Regulatory Solutions in anticipation of its disposal. Prior reported ARR growth is shown for context; dollar levels across differently scoped quarters are not a sequential sales measure.

Key Topics & Management Commentary

Overall Management Tone: Management retained the confidence of February’s outlook but attached a clearer condition to the ratings recovery. The call was persuasive on customer use cases and cost discipline, while the timing of large AI contracts and the duration of issuance disruption remained less certain.

1. Structural funding needs still pass through cyclical issuance windows

AI infrastructure, energy transition and private capital need financing over many years. That supports Moody’s franchise, but it does not guarantee fee recognition in any particular quarter. More than $100 billion of jumbo AI-related financings helped Q1; the annual plan still assumes only low-single-digit growth in total rated issuance.

“In Ratings, as I said, issuance remains anchored in long-term funding needs tied to AI-driven infrastructure, private credit, energy transition in emerging markets. And these are multiyear funding needs. They're not short-term cycles. And as I said, volatility may affect timing, but the underlying demand is structural. And that showed up clearly in Q1.”

— Rob Fauber, President & CEO

Assessment: We treat infrastructure as support for ratings demand through the cycle, while underwriting the current year against actual reopening of debt markets. That distinction keeps our EPS forecast at the guidance midpoint instead of annualizing Q1’s $4.33.

2. Private credit scrutiny can create demand for independent assessment

MIS private-credit-related revenue grew more than 80% year over year. The opportunity is not limited to financing new loans: investors and insurers also want comparable assessments of existing portfolios. Some financing migrated from private to public markets, where Moody’s can still earn fees.

“It's exactly what you'd expect that we are seeing aspects of what I call investor demand pull or the investors in private credit are starting to say, we'd like to have a third-party independent credit assessment on these loans that are in the fund that I'm invested in. You're starting to see alternative asset managers make disclosures about how much of their portfolio is rated or the insurers are doing that and by whom. So -- and that's because the underlying investors are asking questions and wanting to have a third-party assessment of credit risk.”

— Rob Fauber, President & CEO

Assessment: The disclosed customer behavior supports a ratings demand opportunity even as credit concerns rise. It does not make Moody’s countercyclical: stressed borrowers may issue less debt, and management did not size private credit’s revenue base. We view the growth as diversification within MIS, not an offset large enough to neutralize a broad issuance slowdown.

3. AI distribution expands access while preserving the customer license

Enterprise integrations place Moody’s data in customers’ existing AI and productivity tools. The commercial attraction is a wider license across a bank or business unit, rather than relying solely on additional specialist seats. That extends February’s strategy of supplying trusted data inside third-party workflows.

“And importantly, these are bring-your-own license models. They expand reach and usage but preserve our direct relationship with our customer.”

— Rob Fauber, President & CEO

Assessment: Direct licensing reduces the risk that a new interface displaces the commercial relationship. It does not yet prove higher spending per customer. Our base case includes the existing high-single-digit ARR trajectory; larger enterprise AI deals are an upside path once trials convert into paying contracts.

4. Efficiency is supporting investment rather than simply reducing ambition

Moody’s is reallocating product and sales resources toward lending, insurance and data, while moving mature products into maintenance and shifting implementation work to partners. The $43 million increase in MA adjusted profit exceeded its $24 million increase in segment costs. MIS also handled record volumes with technology improvements around the ratings committee.

“Turning to profitability. MA adjusted operating margin was 32.5% and that's up 250 basis points year-over-year. We are well on track for full year margin of 34% to 35% and our mid- to high 30s target by the end of 2027. This expansion reflects the impact of prior restructuring actions, disciplined cost management as well as a thoughtful reallocation of resources, which enables us to fund priorities without increasing costs. As we look ahead, margins are expected to continue improving as efficiency initiatives scale, including usage of AI-enabled tools that lower unit costs in product development and tighter alignment of sales capacity to our highest growth opportunity with full benefit building into 2027.”

— Noémie Heuland, CFO

Assessment: The cost trajectory supports our 34.5% full-year MA margin assumption and further improvement in 2027. Q1’s 32.5% still requires a meaningful second-half step-up. We attribute the improvement to the combined restructuring, resource allocation and technology program; the call did not isolate AI savings in dollars.

5. Strong cash flow funds faster repurchases, but the cash release is not all recurring

Operating cash flow rose $182 million to $939 million. A $133 million improvement in the net change in other operating assets and liabilities supplied much of that increase. Free cash flow reached $844 million after $95 million of capital spending, while treasury-share purchases and dividends consumed $1.656 billion. Cash fell from $2.384 billion at year-end to $1.469 billion.

“Given the nearly $1.5 billion of buybacks executed in Q1, we have increased our full year repurchase guidance by $500 million and now expect approximately $2.5 billion of share buybacks in 2026. We remain on track to return approximately 110% of free cash flow to shareholders by year-end.”

— Noémie Heuland, CFO

Assessment: Repurchases can support EPS even if organic growth remains steady, but they have drawn on existing liquidity. With the full-year free-cash-flow outlook unchanged at $2.8–$3.0 billion, our valuation uses earnings and cash generation rather than assuming the Q1 cash-flow growth rate persists. The expected sale also helps explain why management can raise capital returns without raising adjusted EPS.

6. Governance supports the data franchise and slows adoption

Regulated banks and insurers need explainable, auditable outputs. That requirement favors established data and risk vendors, but it also lengthens implementation and procurement. The incoming analytics CEO, Christina Kosmowski, starts in June; turning a growing enterprise pipeline into deployments will matter more than the appointment itself.

“So that does I think that -- we've seen that it takes a little bit longer for adoption with these big regulated institutions because they've got to satisfy not only their internal environment, but make sure that the third parties that they're working with have the same kind of controls and governance that their regulators are going to expect of them.”

— Rob Fauber, President & CEO

Assessment: Customer governance is a plausible barrier to replacement, with a corresponding constraint on the speed of AI sales. New stablecoin methodology and on-chain ratings capabilities extend the franchise into digital finance, but no separate revenue contribution is necessary to support our current earnings forecast.

Guidance & Outlook

The roughly $1.25 per-share expected divestiture gain is excluded from adjusted EPS. GAAP guidance also incorporates about $0.25 for the tax-related obligation and about $0.10 of duplicative headquarters rent. The higher GAAP range is therefore not an upgrade to recurring earning power.

“Our base case assumes the current market turbulence is largely contained to April with issuance recovering through Q2 and Q3 on the back of ongoing refinancing needs, a healthy M&A pipeline and sustained demand for high-quality investment-grade issuance, including AI-related financing. For the second quarter, we expect MIS revenue growth in the low to mid-teens with adjusted diluted EPS of approximately $4.15 to $4.30. If volatility persists beyond April, we'd have less confidence in a full recovery in Q2 and Q3 and would expect full year MIS revenue growth to moderate to the mid-single-digit range with adjusted diluted EPS trending towards the low end of our guidance range.”

— Noémie Heuland, CFO

Required delivery: At the $16.70 annual EPS midpoint, Q2–Q4 must contribute $12.37, or $4.12 per quarter on average. Q2 guidance of $4.15–$4.30 implies a 0.7–4.2% sequential decline from Q1. At the Q2 midpoint of $4.225, H2 must deliver $8.145, roughly $4.07 per quarter. That is achievable without another record quarter, but still depends on issuance recovery and improving MA margins.

Estimate outlook: Contemporary FY adjusted EPS expectations of $16.65–$16.68 sit close to management’s midpoint, and the $4.23 Q2 expectation is near the quarterly guide midpoint. Our $8.25 billion revenue estimate is also close to the $8.26 billion FY expectation. There is little immediate estimate upside from simply reaffirming the ranges.

Guidance style: Management’s confidence is conditional, rather than an unconditional cushion. The base case assumes volatility fades after April; continued softness in May would undermine a full Q2–Q3 catch-up. MA also needs better sales execution and a more pronounced second-half margin improvement. These are the commitments against which the next quarter should be judged.

Analyst Q&A Highlights

Enterprise AI trials: the license opportunity is clearer than the conversion rate

The discussion tested whether expanded AI distribution has already become a measurable commercial business. Management described active trials and a mechanism for larger institutional licenses, but supplied no customer count or conversion rate.

Q: “You talked about your MCP strategy allowing Moody's data to be accessed through LLM. Can you discuss how many customers are accessing Moody's data through these channels and what your plans are to monetize MCP distribution?”

— George Tong, Goldman Sachs

A: “We have, I would say, a number of large financial institutions who are trialing, I'm going to call this our agent ready data through either the MCPs directly into the institution or through one of these channels. And what that does is it allows us the opportunity to up-level the commercial model that we have with these institutions, right? Because if they want to bring our intelligence into the corporate and investment bank, we need to make sure that there's an arrangement and a license that allows them to access that content across that entire division as opposed to in the past, we may have had been serving different use cases in different parts of the bank. So I would say it's in early days. Lots of really good engagement of number now of trials, and we'll be looking to convert those to obviously, the sales through the balance of the year. The one other thing I'd say is -- sometimes it will also depend on the kind of institution or what the use case is for some of this. So we may see some of this show up in different segments across MA.”

— Rob Fauber, President & CEO

Assessment: Management answered how distribution could monetize, while leaving the requested adoption count unresolved. The useful milestone is conversion of trials through the balance of 2026. Until then, the value of wider access is mainly protection of Moody’s relevance in customer workflows, with incremental revenue still contingent.

Hyperscaler issuance does not carry uniform economics per dollar

The question challenged whether very large AI financings translate proportionately into fees. Management put hyperscalers in the frequent investment-grade issuer category.

Q: “Rob, I was hoping you could just give us an update on how you're thinking about the hyperscalers and if you've seen a number of them move to the frequent issuer program and whether the economics there are sort of similar to other IG issues? And I guess, has that created sort of a price dilution or a mix dilution between sort of when we look at the issuance numbers and ratings revenue, is that one of the factors that would drive sort of a delta there? And should we expect that to continue as we see this sort of massive hyperscaler issuance over the next few years?”

— Toni Kaplan, Morgan Stanley

A: “Toni, good question. I'm glad you asked it because I mentioned kind of $100 billion-ish hyperscaler issuance through the first quarter. That's a big number, and that's getting close to what we were thinking of for the full year for 2026. So it is possible there's some upside to that through the balance of the year. But I'm glad you asked the question because I would say hyperscalers are, in many ways, no different than any other what you would think of as frequent investment-grade issuer. And we always talk about some of our serial investment-grade issuers are on frequent issuer pricing programs, which is why there's a little bit different revenue mix on investment grade versus spec grade, and that's true here. So when you see these big numbers around hyperscaler issuance, just think of that as frequent investment-grade issuer kind of issuance.”

— Rob Fauber, President & CEO

Assessment: The answer limits the revenue inference from spectacular financing totals. Large issuers can have different pricing arrangements, so our MIS revenue forecast relies on the mix of investment grade, high yield, loans and monitoring fees. More AI debt is favorable, but a dollar of issuance is not a constant unit of Moody’s earnings.

KYC’s return to mid-teens growth needs the corporate offering to build

The exchange separated a difficult comparison from a deterioration in customer demand. Management pointed to stronger retention and a new corporate platform as reasons for expecting improvement.

Q: “So I wanted to see if you could discuss a bit more about KYC and some of the trends that you're seeing there and the longer-term opportunity? And if some of the slowdown was due to macro later in the quarter?”

— Sean Kennedy, Mizuho

A: “So for KYC, 13% ARR growth, we had a little bit of a tough comp for new business versus the first quarter last year. We had a couple of outsized deals last quarter. Retention improved pretty notably as we lapse those cancellations that we had last year, most of that was related to DOGE. I would say, Sean, that we think growth is going to pick back up into the mid-teens through the balance of the year. We've got some new use cases and new product launches. Probably the most important of those is the one that I just mentioned briefly in my prepared remarks, which is what we call Moody's for compliance. Think of that as a kind of a platform solution that serves nonregulated institutions, corporates and so on. So we've been building pipeline on that. We expect that to continue through the balance of the year. Most of our growth so far has been from cross-selling to existing banking customers, and we're starting to see that corporate growth pick up. So I think the key message here is that we expect ARR growth to pick up through the balance of the year into that kind of mid-teens number.”

— Rob Fauber, President & CEO

Assessment: The comparison and churn explanation supports a recovery, but the causal bridge also requires new-product demand. Mid-teens KYC ARR growth is an observable commitment for later quarters. A persistent 13% pace would leave less room for other analytics businesses to remain at mid-single-digit growth.

Lower transaction revenue will keep reported growth below contract growth

The challenge was whether portfolio cleanup is nearly complete or will keep distorting analytics growth into 2027. Management explicitly extended the decline in implementation and services revenue beyond this year.

Q: “Yes. Staying on MA, and this is also Noemie, just a little bit more of a numbers question here, but obviously, the transactional side of that business, I think, is the lowest quarter on record, I think $17 million. So obviously, done a lot I know you deemphasizing. So just the question is, is this kind of it now? Is this kind of a good run rate to use for the rest of the year? And does that mean that as we think about 2027, you're finally getting to the point where like ARR and recurring revenue growth and overall growth kind of start converging? Or is there still more to go? And can there still be more lumpiness on the transactional side here. I'm just trying to understand like really what's happening on that side?”

— Alex Kramm, UBS

A: “When it comes to transaction revenue, you have the effect of the learning solution divestiture in Q1 number. That's why you have the down dip in that number in Q1, which was expected. So you'll continue to see that carrying through the rest of the year. We had a double-digit decline in transaction revenue, which we continue to expect as we move services, integration work to our partners. We don't want those on our paper. We're obviously here to support our customers as they go through migration and implementation, but those revenues are now being recorded outside of our books. So you'll continue to see that carrying through '26 and '27. However, if you look at, again, organic constant currency growth for recurring revenue, that's really much aligned now with ARR, you can have a few lumpiness in a given quarter if we have on-premise revenue recognition for long-term software arrangement that could create a little bit of variation. But on a trailing 12-month basis, that's pretty close.”

— Noémie Heuland, CFO

Assessment: The answer argues against an immediate convergence of total revenue and ARR growth. Moving implementation work to partners improves scalability, but removes revenue from Moody’s books. We expect the benefit first in margins and recurring mix, with organic recurring revenue a better measure of demand than total reported growth during the transition.

The issuance-recovery analogy has an explicit limit

The question pressed how the Iran conflict, inflation and shifting spreads had been reflected in unchanged guidance. Management used the prior year’s tariff disruption to explain why delayed issuance might return, then identified continued May weakness as the point at which confidence would deteriorate.

Q: “A little bit more of a broader question in terms of the guidance. And I know it's a fluid situation geopolitically, but I'm just wondering how did you incorporate the war in Iran, what's going on and the potential impact to inflation and anything else in terms of spreads going up and down into the guidance? I know you mentioned the guidance talked a little bit about volatility. But like when you think about it through the year, and your decision to keep the guidance there. How are you thinking about it as it goes through both MIS and MA?”

— Shlomo Rosenbaum, Stifel

A: “Yes. I'll focus probably mostly on ratings just because I think that's where more -- there's more variability given the geopolitical backdrop. But obviously, the Iran war is the most important variable is interesting actually because we were thinking back at the first quarter call this time last year. And if you remember, there were the liberation day tariffs. And it was very -- it created a lot of volatility and uncertainty in the market. And what we saw through the balance of the year was that, that volatility resulted in considerably lower issuance levels in April last year. But then we saw that get made up for the back half of the year, right? And we ultimately ended up essentially right in line with our original full year guidance. So I think we're -- we feel like we're in a little bit of the same situation. It's April 22. There's still a long way to go in the year. There's actually an interesting stat, Shlomo, that in March, 80% of investment-grade issuance was in 6 days. That's pretty remarkable. And that tells you a couple of things. I mean one, it just shows you kind of the risk on, risk off windows that were going on in March. But two, it also shows you how much demand there is that was just waiting until there's a risk on window and that demand hits the market. So it goes back to all these things about the underlying funding drivers, the demand drivers for raising capital, those are still there. And so Noemie talked a little bit about in her prepared remarks that if we see heightened volatility that goes on into May, and we see real softness in the month of May, I think at that point, we're probably going to -- Noemie gave you a sense of what that would mean for our guidance. But right from where we sit right now, given the conditions that I talked about, given the underlying drivers and given the fact we're still in April, we think it's most prudent to hold to our current guidance. And when we talk to the banks, that's the same thing we hear from them as well.”

— Rob Fauber, President & CEO

Assessment: The analogy is plausible because borrowers retain funding needs, but it is not a guarantee that this shock follows the same path. Management did address the downside rather than simply reaffirming guidance: persistent disruption would lower MIS growth and push EPS toward the annual floor. That limited near-term visibility is the main reason a solid quarter does not earn a more favorable rating at this valuation.

What They’re NOT Saying

1. AI revenue, adoption counts and conversion economics: Management described trials, license scope and use cases, but did not quantify the incremental revenue from the newest channels. Without contract conversion, engagement cannot support a distinct near-term estimate uplift.
2. A private-credit revenue base or fee sensitivity: Growth above 80% is impressive, but its dollar weight remains unclear. It is insufficient to conclude that greater demand for credit assessment would offset lost issuance during a credit contraction.
3. A quantified split of technology savings: The 70-basis-point MIS margin expansion reflects the combined volume and cost program. No bridge isolates AI’s contribution, which limits how much additional efficiency can be extrapolated independently of revenue.
4. A detailed quarterly MA margin bridge: Management expects a modest Q2 step-up and stronger H2 improvement, but does not identify how much comes from product mix, divestiture, restructuring or new sales. The annual target remains exposed to the sales cadence.

Market Reaction

• Entering the print: MCO closed April 21 at $459.59, down 10.0% year to date against a 3.2% S&P 500 gain. It had risen 4.2% over the prior 30 days and 6.9% over the trailing twelve months.
• April 22 reaction session: Shares opened at $474.27 and traded between $464.57 and $482.54 before closing at $466.72, up $7.13 or 1.6%. Volume was approximately 1.6 million shares, 1.4 times the preceding 30-session average.
• Market context: The S&P 500 and peer S&P Global each rose 1.0% on the session. MCO’s pre-print 52-week closing range was $412.23–$539.61.

Relief after underperformance: In our view, the small EPS beat, intact adjusted earnings range and $500 million increase in repurchase guidance help explain the positive response. That interpretation fits a stock entering earnings well behind the index. The advance provides evidence of improved sentiment, rather than proof that investors resolved the AI or issuance debates.

The close retained less enthusiasm than the open: MCO finished below its opening price despite outperforming the index over the full session. The result is consistent with recognition of earnings durability alongside caution about the recovery assumptions.

Street Perspective

Debate: structural financing demand versus an interruption in issuance

Bull view: Infrastructure spending, refinancing and private capital create funding needs that survive temporary market closures. Deferred deals can return quickly when volatility falls.

Bear view: Repeated short issuance windows can defer enough volume to matter for annual earnings, especially when weaker borrowers face more selective demand.

Our take: The long-term funding case is stronger than the claim that Q1 was merely borrowed from future quarters. But the annual midpoint still requires reopening, so the near-term downside deserves weight in the price paid for those future fees.

Debate: AI strengthens the data franchise or changes who captures its value

Bull view: Trusted, auditable data becomes more valuable as automated workflows expand, and broader enterprise licensing can increase wallet share.

Bear view: New interfaces change purchasing behavior and invite competition, while extensive trials may take time to generate revenue.

Our take: Continued retention and direct licensing favor the resilience argument today. They are not yet evidence of a faster total growth rate. Our earnings estimate includes continued adoption within the existing trajectory, with no separate multiple premium for announced AI channels.

Debate: capital returns and margins compensate for moderate organic growth

Bull view: Expanding margins and a shrinking share base allow double-digit EPS growth without double-digit sales growth.

Bear view: Repurchases at a premium multiple offer less earnings accretion per dollar, and a plan to return more than annual free cash flow leaves less internal flexibility if issuance weakens.

Our take: The combination supports a quality earnings profile, but it is already visible in a stock valued near 28 times our FY2026 EPS. The return case is mainly earnings progression into 2027, with little justification for a second gain from multiple expansion.

Model Implications & Valuation

Our first estimates

We expect FY2026 adjusted EPS of $16.70, matching the midpoint of management’s unchanged range, and FY2027 adjusted EPS of approximately $18.20. MA reported growth of 4.5% on the 2025 base of $3.599 billion and MIS growth of 9% on $4.119 billion imply approximately $8.25 billion of FY2026 revenue. The mix places consolidated growth near the lower end of management’s high-single-digit range.

Earnings bridge: For FY2026, ($8.25 billion × 52.5% − $0.280 billion − $0.190 billion) × 76% ÷ 175.7 million shares yields $16.70. For FY2027, 7% revenue growth and a 50-basis-point margin gain produce $4.68 billion of adjusted operating income. After $295 million of retained depreciation and amortization, $215 million of normalized non-operating expense, a 24% tax rate and 174 million shares, EPS is about $18.20. These are our operating assumptions; the 2027 projection is not company guidance.

The forecast requires roughly 35% MA adjusted margins over the balance of 2026 after Q1’s 32.5%, with more improvement later in the year. Our $16.70 EPS also implies $12.37 over the remaining three quarters. The forecast therefore embeds a recovery, but no step-change in AI sales. A one-percentage-point change in consolidated margin at our FY2026 revenue and share count changes annual EPS by approximately $0.36, illustrating the sensitivity to the cost and sales plan.

Twelve-month valuation and downside

Returns include an assumed $4.12 of dividends over twelve months, using the declared quarterly rate of $1.03 without assuming an increase. All scenarios value FY2027 adjusted earnings. Scenario multiples and earnings are our assumptions.

Why 27.5 times: Moody’s recurring contracts, ratings franchise and high cash conversion warrant a premium in our view. But growth is still tied to debt-market access and the analytics margin ramp. We therefore apply 27.5 times FY2027 EPS, slightly below the 28.0 times FY2026 earnings embedded in today’s price, rather than adding an AI-driven rerating. The base return comes largely from earnings growth. A one-turn change in the base multiple changes value by $18.20 per share, or 3.9% of the starting price.

Scenario discipline: The bear case assumes $8.50 billion of 2027 revenue, a 51% adjusted margin, $300 million of retained depreciation and amortization, $370 million of normalized net non-operating expense, 24% tax and 174 million shares, yielding approximately $16.00 EPS. It combines weaker activity, operating deleverage and a funding-cost headwind. The bull case assumes $9.00 billion revenue, a 53.5% margin, $295 million of retained depreciation and amortization, $190 million normalized net non-operating expense, 24% tax and 173 million shares, yielding approximately $19.00. The lower bear multiple reflects both slower earnings and the loss of confidence in near-term growth.

Rating consequence: Our base total return of 8.1% broadly matches an explicit 8% twelve-month S&P 500 return assumption. That benchmark is an underwriting assumption, not a market forecast presented as fact. With roughly 17% downside in a credible adverse case, the small prospective advantage does not support Outperform. We initiate at Hold.

Thesis Scorecard Post-Earnings

This first-coverage scorecard establishes the investment case: a durable ratings and analytics franchise can compound earnings through margin improvement, but the price offers limited protection against interruption in the recovery.

What would change our view: A firmer rating would require observable issuance recovery in May and June, delivery of the $4.15–$4.30 Q2 EPS outlook, progress toward 34–35% MA margins and conversion of enterprise AI trials that improves the earnings path beyond our base. KYC returning to mid-teens ARR growth would reinforce that case. Prolonged issuance weakness, a cut to MA’s margin objective or deteriorating retention would move the balance toward Underperform if the valuation remained near today’s level.

Overall: The quarter establishes a sound operating thesis with active timing and valuation risks. The unchanged adjusted EPS range and more conditional recovery outlook are consistent with our midpoint forecast; they do not justify a more optimistic multiple.

Action: Initiate at Hold, with approximately $501 of twelve-month value and an expected total return broadly in line with the S&P 500. Durable earnings alone are not enough to create attractive excess returns at the current price.